Insurance expansion associated with increase in surgical treatment of thyroid cancer

April 05, 2017

The 2006 Massachusetts health reform, a model for the Affordable Care Act, was associated with significant increases in surgical intervention for thyroid cancer, specifically among nonwhite populations, according to a study published by JAMA Surgery.

The incidence of thyroid cancer has been increasing by 5 percent each year over the last decade. While the rise is likely multifactorial, including the possibility of overdiagnosis, there has been little consideration of the effect of insurance statuses on the treatment of thyroid cancer. Benjamin C. James, M.D., M.S., of the Indiana University School of Medicine, Indianapolis, and colleagues evaluated the association of insurance expansion with thyroid cancer treatment using the 2006 Massachusetts health reform. The researchers used the Agency for Healthcare Research and Quality State Inpatient Databases to identify patients with government-subsidized or self-pay insurance or private insurance who were admitted to a hospital with thyroid cancer and underwent a thyroidectomy (removal of all or part of the thyroid gland) between 2001 and 2011 in Massachusetts (n = 8,534) and three control states (n = 48,047).

Before the 2006 Massachusetts insurance expansion, patients with government-subsidized or self-pay insurance had lower thyroidectomy rates for thyroid cancer in Massachusetts and the control states compared with patients with private insurance. The researchers found that the Massachusetts insurance expansion was associated with a 26 percent increased rate of thyroidectomy and a 22 percent increased rate of neck dissections for thyroid cancer. The increased rate occurred disproportionately among nonwhite patients, with a 68 percent increased rate of undergoing a thyroidectomy and 45 percent increased rate of undergoing neck dissections among nonwhite patients compared with control states.

"Our findings provide encouraging evidence that insurance coverage may help mitigate racial or socioeconomic disparities while also raising questions concerning the relative appropriateness of the observed management of thyroid cancer, which deserves additional investigation," the authors write

"Our study suggests that insurance expansion may be associated with increased access to the surgical management of thyroid cancer. Further studies need to be conducted to evaluate the effect of healthcare expansion at a national level."
-end-
(JAMA Surgery. Published online April 5, 2017.doi:10.1001/jamasurg.2017.0461. This study is available pre-embargo at the For The Media website.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

The JAMA Network Journals

Related Thyroid Cancer Articles from Brightsurf:

Trends in the global burden of thyroid cancer
This study examined the worldwide trends of thyroid cancer from 1990 to 2017 according to geographic location, sex, age and socioeconomic factors.

Cancer treatment with immune checkpoint inhibitors may lead to thyroid dysfunction
Thyroid dysfunction following cancer treatment with new treatments called immune checkpoint inhibitors is more common than previously thought, according to research that was accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and will be published in a special supplemental section of the Journal of the Endocrine Society.

Thyroid cancer, genetic variations, cell phones linked in YSPH study
Radiation from cell phones is associated with higher rates of thyroid cancer among people with genetic variations in specific genes, a new study led by the Yale School of Public Health finds.

AJR researchers take step toward automating thyroid cancer triage
An article published ahead-of-print in the April issue of the American Journal of Roentgenology (AJR) details how a Stanford University team developed a quantitative framework able to sonographically differentiate between benign and malignant thyroid nodules at a level comparable to that of expert radiologists, which could provide second-opinion malignancy risk estimation to clinicians and ultimately help decrease the number of unnecessary biopsies and surgical procedures.

Thyroid cancer rates in US
An analysis suggests rates of thyroid cancer in the US appear to have plateaued in recent years after decades on the rise.

Using artificial intelligence to predict risk of thyroid cancer on ultrasound
New study uses machine learning on ultrasound images of thyroid nodules to predict risk of malignancy.

For low-risk thyroid cancer patients, less may be more for post-surgery surveillance
Patient self-advocacy is important, and although a maximizing preference may be advantageous in many situations, new research led by the University of Michigan Rogel Cancer Center shows that, in the case of long-term surveillance of treated, low-risk thyroid cancer, health care ''maximizers'' consume more health care resources -- such as doctor visits and diagnostic imaging tests -- which drive up costs without a clear improvement in outcomes.

New test for thyroid cancer could prevent unnecessary surgery
Each year, thanks to inconclusive tests for thyroid cancer, thousands of people undergo unnecessary surgeries to remove part or all of their thyroids.

Raman spectroscopy poised to make thyroid cancer diagnosis less invasive
Researchers have demonstrated that an optical technique known as Raman spectroscopy can be used to differentiate between benign and cancerous thyroid cells.

Are doctors treating more thyroid cancer patients than necessary?
New research may help change treatment practices for patients diagnosed with low risk thyroid cancer.

Read More: Thyroid Cancer News and Thyroid Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.